TY  - JOUR
TI  - Different perspectives on translational genomics in personalized medicine
AB  - Personalized medicine is a relatively new and interesting concept in the medical and healthcare industries. New approaches in current research have supported the search for biomarkers, based on the genomic, epigenomic and proteomic profile of individuals, using new technological tools. This perspective involves the potential to determine optimal medical interventions and provide the optimal benefit-risk balance for treatment, whilst it also takes a patient’s personal situation into consideration. Translational genomics, a subfield of personalized medicine, is changing medical practice, by facilitating clinical or non-clinical screening tests, informing diagnoses and therapeutics, and routinely offering personalized health-risk assessments and personalized treatments. Further research into translational genomics will play a critical role in creating a new approach to cancer, pharmacogenomics, and women’s health. Our current knowledge may be used to develop new solutions that can be used to minimize, improve, manage, and delay the symptoms of diseases in real-time and maintain a healthy lifestyle. In this review, we define and discuss the current status of translational genomics in some special areas including integration into research and health care. (J Turk Ger Gynecol Assoc 2022; 23: 314-21)
AU  - gunel, tuba
AU  - Diz-Kucukkaya, Reyhan
AU  - göksever çelik, hale
AU  - Gumusoglu-Acar, Ece
AU  - Doğan, Berkcan
DO  - 10.4274/jtgga.galenos.2022.2021-11-4
PY  - 2022
JO  - Journal of the Turkish-German Gynecological Association
VL  - 23
IS  - 4
SN  - 1309-0399
SP  - 314
EP  - 321
DB  - TRDizin
UR  - http://search/yayin/detay/1165492
ER  -